An econometric analysis of screening and treatment of patients with suspected Chlamydia.
- 1 January 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in Health Care Management Science
- Vol. 5 (1), 33-39
- https://doi.org/10.1023/a:1013249018847
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Epidemiologic and Microbiologic Correlates of Chlamydia trachomatis Infection in Sexual PartnershipsJAMA, 1996
- Prevention of Pelvic Inflammatory Disease by Screening for Cervical Chlamydial InfectionNew England Journal of Medicine, 1996
- New Opportunities for Chlamydia PreventionSexually Transmitted Diseases, 1995
- Chlamydia trachomatis and sexually transmitted diseaseBMJ, 1994
- Compliance with Antibiotic Therapy for Chlamydia trachomatis and Neisseria gonorrhoeaeSexually Transmitted Diseases, 1992
- A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males.Sexually Transmitted Infections, 1992
- A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and CervicitisNew England Journal of Medicine, 1992
- Prevalence of Chlamydia trachomatis infection in women having cervical smear tests.BMJ, 1991
- Azithromycin in the treatment of sexually transmitted diseaseJournal of Antimicrobial Chemotherapy, 1990
- Criteria for Selective Screening for Chlamydia trachomatis Infection in Women Attending Family Planning ClinicsJAMA, 1986